Biotech

All Articles

BioMarin standstills preclinical gene treatment for heart condition

.After BioMarin conducted a spring clean of its pipeline in April, the provider has decided that it ...

Eisai plants molecular glue SEED along with $1.5 B biobucks work

.Major Pharmas stay stuck to the concept of molecular adhesive degraders. The most up to date compan...

Life scientific research credit score agency introduces with $600M

.A brand new worldwide life science credit scores organization, referred to as Symbiotic Financing, ...

BMS channels TIGIT, leaving $200M bet on Agenus bispecific

.Bristol Myers Squibb is actually axing another huge bet coming from the Caforio era, ending a barga...

Nuvation halts wager inhibitor after taking into consideration stage 1 information

.After looking at phase 1 information, Nuvation Bio has decided to halt deal with its own one-time l...

' Clinical intuition' led FDA experts to back Zevra's rare health condition med

.Zevra Rehabs' uncommon health condition medicine seems to be on the course to permission this fall ...

Pfizer takes $230M struck after axing failed DMD gene treatment

.Pfizer's stage 3 Duchenne muscular dystrophy (DMD) gene treatment breakdown has actually blown a $2...

AC Immune finds 'site' prospective in Alzheimer's medication records

.After greater than two decades of focus on neurodegenerative ailments, Swiss biotech air conditione...

GSK loses ph. 2 HPV injection over lack of best-in-class potential

.GSK has junked a stage 2 human papillomavirus (HPV) injection coming from its pipe after choosing t...

OS Therapies refiles $6M IPO to cash HER2 drug, preclinical ADCs

.OS Therapies will definitely provide on the NYSE American inventory substitution today via a $6.4 t...